TimesSquare Capital Management LLC Has $53.51 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)

TimesSquare Capital Management LLC trimmed its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 11.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 553,711 shares of the company's stock after selling 73,055 shares during the period. TimesSquare Capital Management LLC owned approximately 0.55% of Encompass Health worth $53,511,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. UMB Bank n.a. lifted its position in shares of Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company's stock worth $31,000 after acquiring an additional 252 shares during the period. V Square Quantitative Management LLC raised its stake in shares of Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after purchasing an additional 140 shares in the last quarter. Oakworth Capital Inc. acquired a new stake in Encompass Health during the second quarter worth $40,000. Benjamin F. Edwards & Company Inc. boosted its position in shares of Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock valued at $46,000 after acquiring an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in Encompass Health in the second quarter valued at about $58,000. 97.25% of the stock is currently owned by institutional investors.

Insider Activity at Encompass Health

In related news, CFO Douglas E. Coltharp sold 12,260 shares of Encompass Health stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the transaction, the chief financial officer now owns 136,227 shares of the company's stock, valued at $11,761,839.18. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Trading Down 0.3 %

EHC stock traded down $0.33 during trading on Friday, hitting $103.20. The company had a trading volume of 620,628 shares, compared to its average volume of 732,598. The stock has a market cap of $10.40 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 1.35 and a beta of 0.88. The company has a quick ratio of 1.35, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a 50-day moving average price of $95.51 and a 200-day moving average price of $89.64. Encompass Health Co. has a 12 month low of $62.58 and a 12 month high of $104.53.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The company's quarterly revenue was up 11.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.86 EPS. As a group, analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health declared that its board has authorized a stock buyback plan on Wednesday, July 24th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 5.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's leadership believes its shares are undervalued.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. Encompass Health's dividend payout ratio is currently 16.43%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on EHC shares. KeyCorp lifted their price objective on Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. Truist Financial reaffirmed a "buy" rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Royal Bank of Canada increased their price objective on Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 30th. Barclays boosted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a research note on Tuesday, October 29th. Finally, Stephens reiterated an "overweight" rating and set a $105.00 target price on shares of Encompass Health in a research report on Tuesday, August 6th. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.